Psycho-oncological Intervention Through Counselling in Patients With Differentiated Thyroid Cancer in Treatment With Radioiodine
NCT05054634 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2021-09-23
Summary
Diagnosis and treatment of differentiated thyroid carcinomas cause anxiety and depression. Additionally, these patients suffer hormonal alterations, associated with psychological symptoms (changes in mood, emotional instability, memory loss, etc.). This study aims to evaluate the effectiveness of a psycho-oncological intervention based on Counselling to reduce anxiety and depression related with the treatment in patients with differentiated thyroid carcinomas.
Conditions
Interventions
- BEHAVIORAL
-
Psycho-oncological Intervention Based on Counselling (PIBC)
Patients in EG received a psycho-oncological intervention based on Counselling (PIBC) following the scheme proposed by Arranz and Cancio in addition to the standard treatment. The evolution of anxiety and depression was evaluated using Hospital Anxiety and Depression Scale (HADS). The aim of the study was to evaluate the effectiveness of a PIBC in reducing anxiety and depression of patients with DTC. Other QoL relevant items were also evaluated using the Short Form-36 Health Survey (SF-36) and Psychological General Well-Being Index (PGWBI) scales.
Sponsors & Collaborators
-
Quironsalud
lead OTHER
Principal Investigators
-
Manuel Sureda, MD · Plataforma de Oncología. Hospital Quironsalud Torrevieja
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-06-01
- Primary Completion
- 2014-09-30
- Completion
- 2015-03-31
Countries
- Spain
Study Locations
More Related Trials
-
Effects of Thyroid Hormone Withdrawal on Metabolic Parameters During Radioactive Iodine Therapy in Thyroid Cancer
NCT01744769 ·Status: UNKNOWN
-
Decision Aid and Thyroid Nodules Management
NCT05264857 ·Status: RECRUITING ·Phase: NA
-
Subclinical Hypothyroidism and Mind in the Elderly
NCT00921050 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Assessment of Quality of Life After Adjunct Radioiodine Therapy in Patients With Differentiated Thyroid Cancer
NCT02706743 ·Status: UNKNOWN
-
Hyperthyroid Follow-Up Study
NCT02989103 ·Status: COMPLETED
-
A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 Tumours
NCT01736163 ·Status: COMPLETED
-
Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma
NCT04354324 ·Status: RECRUITING ·Phase: NA
-
The Effects of T4 Versus T4/T3 on Psychological Distress After Total Thyroidectomy in Thyroid Cancer Patients
NCT03024151 ·Status: COMPLETED ·Phase: NA
-
Shared Care Thyroid Cancer Follow-up Utilizing Thyroid Cancer Assessment Reminder System (TCARS) Study - A Pilot Study.
NCT05510934 ·Status: RECRUITING
-
Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
NCT01837745 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
NCT03624751 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer
NCT00251316 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
NCT05733013 ·Status: RECRUITING
-
Testicular Function After Iodine 131 Therapy in Papillary Carcinoma Patients
NCT01150318 ·Status: COMPLETED ·Phase: NA
-
Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.
NCT00001730 ·Status: COMPLETED ·Phase: PHASE4
-
Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis)
NCT02156362 ·Status: UNKNOWN ·Phase: NA
-
Mapping Patient Decision-making in Thyroid Cancer
NCT06411834 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer
NCT02393690 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123
NCT02278198 ·Status: COMPLETED ·Phase: PHASE1
-
Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up
NCT04290663 ·Status: RECRUITING ·Phase: PHASE3
-
Developing and Implementing an Interdisciplinary Team-Based Care Approach (ITCA-ThyCa) for Thyroid Cancer Patients
NCT01994200 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer
NCT02418247 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration
NCT00196729 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Hypothyroidism Incidence After Breast Cancer Supraclavicular Irradiation
NCT02824016 ·Status: COMPLETED ·Phase: NA
-
Thyroid Dysfunction Induced by Anti-PD-1 Therapy in Patients With Advanced Carcinoma
NCT05593744 ·Status: COMPLETED